Clinical Trial Update: The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining whether adding androgen deprivation therapy to docetaxel and prednisolone chemotherapy improves outcomes in castration-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Asan Medical Center | Conditions: Castration-resistant Prostate Cancer | Phase 2 | Status: UNKNOWN